Home > About Japan Comprehensive Cancer Network, Breast (JCCNB) > 2009FY


NCCN/JCCNB Seminar (Testing methods for estimating prognosis and benefits of systemic treatment: current status and future perspectives -Comparative review of Oncotype DX, MammaPrint etc)

Date October 18
Venue Tokyo International Forum
  • Joan McClure (Senior Vice President of NCCN)
  • Robert Carlson (Professor, Division of Oncology, Stanford University. Medical Center)
  • John Ward (Professor and Chief of Oncology Division
  • Department of Medicine, University of Utah School of Medicine)
  • Laura van’t Veer, PhD (Chief Research Officer and Co-Founder of Agendia)
  • Steve Shak,MD (Chief Medical Officer, Genomic Health, Inc)
  • Seigo Nakamura (Director of Breast Surgical Oncology, St. Luke’s International Hospital)
  • Masakazu Toi (Professor, Department of Breast Surgery , Graduate School of medicine, Kyoto University)
  • Yasuhiro Fujiwara (Director, Outpatient Treatment Center and Clinical Trial Coordinating , National Cancer Center Hospital)


JCCNB Seminar

The 5th JCCNB Seminar (Apr 11)
Place: Teusler Hall / 43 Attendants
Report of International Conferences
(The 62th Society of Surgical Oncology, Cancer Symposium)
(St.Gallen Oncology Conferences)

The 6th JCCNB Seminar (Jun 6)
Place: Teusler Hall / 28 Attendants
Report on ASCO Annual Meeting

The 7th JCCNB Seminar (Dec 19)
Place: Teusler Hall / 31 Attendants
Report on the San Antonio Breast cancer Symposium


Translation of Guideline

Guidelines for Treatment of Breast Cancer

  • Breast Cancer
  • Breast Cancer Risk Reduction
  • Breast Cancer Screening and Diagnosis
  • Genetics/Familial High-Risk Assessment:Breast and Ovarian

Guidelines for Supportive Care

  • Distress Management
  • Palliative Care
  • Cancer-Related Fatigue
  • Adult Cancer Pain
  • Antiemesis
  • Cancer-and Treatment-Related Anemia
  • Prevention and Treatment of Cancer-Related infections
  • Myeloid Growth Factors
  • Senior Adult Oncology
  • Venous Thromboembolic Disease